Results 41 to 50 of about 202 (131)

RNA‐Based Therapies for Inherited Metabolic Disorders

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
ABSTRACT Inherited metabolic disorders (IMDs) are a diverse and complex group of genetic conditions resulting from deficiencies in enzymes, transporters, or cofactors. These deficiencies lead to metabolic dysfunction and severe clinical consequences. Despite significant progress in understanding their molecular basis, treatment options remain limited ...
Reddy Sreekanth Vootukuri   +5 more
wiley   +1 more source

Expert‐Designed Fact Sheets and AI‐Based Analysis of Patient Symptoms to Combat Diagnostic Delays in Inherited Metabolic Diseases

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
ABSTRACT The importance of early diagnosis of inherited metabolic diseases (IMDs) is well known, as it allows early intervention to prevent or reduce complications and improve prognosis, since many of these disorders are treatable. However, diagnosis can still be delayed, and many patients remain undiagnosed. Reducing diagnosis delays is a primary goal
Aline Cano   +108 more
wiley   +1 more source

Organoids for Metabolic Disease Modeling

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
ABSTRACT Inherited metabolic diseases (IMDs) are a diverse group of rare genetic disorders that disrupt metabolic pathways, leading to severe clinical manifestations. Disease models ranging from complex animal models to simple in vitro systems have provided insights into IMDs, but each has limitations.
Arif Ibrahim Ardisasmita   +2 more
wiley   +1 more source

Surgical Management of Congenital Lung Malformations in Children—A Single‐Center Analysis of 25 Years of Experience

open access: yesThe Clinical Respiratory Journal, Volume 20, Issue 2, February 2026.
Early diagnosis and intervention are critical for improving prognosis in children with congenital lung malformations (CLM). Fetal diagnosis of CLM generally leads to favorable outcomes; however, there is limited evidence on the effectiveness of fetal therapy in improving outcomes for these anomalies.
Patrycja Sosnowska‐Sienkiewicz   +4 more
wiley   +1 more source

Glycogen Storage Disease in Twins: When Two Lives Reflect One Silent Battle

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Early recognition of hepatomegaly, hypoglycemia, and elevated liver enzymes in infants is crucial for diagnosing glycogen storage disease. Liver biopsy with PAS–diastase staining provides definitive confirmation. Prompt metabolic management and regular follow‐up are essential to prevent progression of fibrosis and long‐term hepatic ...
Rajat Kumar Shah   +10 more
wiley   +1 more source

Errores Congénitos del Metabolismo en edad pediátrica [PDF]

open access: yes, 2013
Los Errores Congénitos del Metabolismo son trastornos poco frecuentes de forma aislada pero en su conjunto suponen un capítulo relevante de la patología pediátrica.
Baña Souto, Ana María
core   +1 more source

Three Unrelated Children With Childhood Apraxia of Speech: Exome Sequencing and Functional Gene Analysis Imply a Role of Laminin‐511 in Early Neurodevelopment

open access: yesCase Reports in Genetics, Volume 2026, Issue 1, 2026.
Childhood apraxia of speech (CAS) is characterized by motor discoordination in the speech domain and also in fine and gross motor systems, implicating the early developing cerebellum. Comorbidity with autism spectrum disorder (ASD) and other neurodevelopmental conditions has been observed. The genetic etiology is highly heterogeneous.
Caitlin Raaz   +11 more
wiley   +1 more source

Implementation of Preoperative Very Low‐Calorie Diets in Preparation for Metabolic and Bariatric Surgery

open access: yesJournal of Nutrition and Metabolism, Volume 2026, Issue 1, 2026.
Very low‐calorie diets (VLCDs) have been commonly implemented prior to metabolic and bariatric surgery (MBS) with the goal of shrinking left liver lobe size and reducing intra‐abdominal mesenteric fat. Through this manuscript, we aimed to review the available literature discussing the types of VLCDs, their mode of implementation, preoperative duration,
Tala Abedalqader   +9 more
wiley   +1 more source

Myo‐Inositol Deficiency, Structural Brain Changes, and Cerebral Perfusion Alterations in Classic Galactosemia: Preliminary Insights From a Multiparametric MRI Study

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Classic galactosemia is a rare metabolic disorder resulting from galactose‐1‐phosphate uridylyltransferase deficiency, which disrupts normal galactose metabolism, leading to toxic accumulation of galactose‐1‐phosphate and galactitol. Despite early dietary intervention, patients remain at risk for long‐term neurological impairments, including ...
Eva Niess   +15 more
wiley   +1 more source

Classical galactosemia:A cloud with a silver lining [PDF]

open access: yes, 2017
For classical galactosemia, (CG), an autosomal recessive inborn error of galactose metabolism, a galactose-restricted diet is the only available treatment.
Welling, L.
core   +2 more sources

Home - About - Disclaimer - Privacy